E-LIB Suche - Ergebnisse für: Mollica, Veronica

1

Tumor growth rate to assess therapy response to immune-base..:

Mollica, Veronica ; Rosellini, Matteo ; Brocchi, Stefano...
Expert Review of Precision Medicine and Drug Development. 9 (2024) 1 - p. 17-24 , 2024

Link: https://doi.org/10.1080/..

2

Overall survival with adjuvant pembrolizumab in renal cell ..:

Massari, Francesco ; Rosellini, Matteo ; Mollica, Veronica
Nature Reviews Urology. , 2024

Link: https://doi.org/10.1038/..

3

Time to strategy failure and treatment beyond progression i..:

Murianni, Veronica ; Signori, Alessio ; Buti, Sebastiano...
Frontiers in Oncology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

4

External validation of a red cell-based blood prognostic sc..:

Maffezzoli, Michele ; Santoni, Matteo ; Mazzaschi, Giulia...
Clinical & Experimental Metastasis. 41 (2024) 2 - p. 117-129 , 2024

Link: https://doi.org/10.1007/..

5

Re: Atezolizumab Plus Cabozantinib Versus Cabozantinib Mono..:

Rosellini, Matteo ; Tassinari, Elisa ; Marchetti, Andrea..
European Urology. 85 (2024) 1 - p. 97-98 , 2024

Link: https://doi.org/10.1016/..

6

Adjuvant treatment in renal cell carcinoma: a never-ending ..:

Mollica, Veronica ; Massari, Francesco
The Lancet. 403 (2024) 10425 - p. 433-434 , 2024

Link: https://doi.org/10.1016/..

7

Clinical Outcomes and Prognostic Factors in Patients With P..:

Mollica, Veronica ; Massari, Francesco ; Maruzzo, Marco...
Clinical Genitourinary Cancer. , 2024

Link: https://doi.org/10.1016/..

8

Assessing the effectiveness and safety of lenvatinib and ev..:

Buti, Sebastiano ; Olivari, Alessandro ; Masini, Cristina...
Therapeutic Advances in Urology. 16 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

9

Papillary Renal Cell Carcinoma: Outcomes for Patients Recei..:

Massari, Francesco ; Mollica, Veronica ; Fiala, Ondrej...
European Urology Oncology. , 2024

Link: https://doi.org/10.1016/..

10

Efficacy of immune checkpoint inhibitors combinations as fi..:

Monteiro, Fernando Sabino Marques ; Soares, Andrey ; Mollica, Veronica...
Critical Reviews in Oncology/Hematology. 196 (2024) - p. 104321 , 2024

Link: https://doi.org/10.1016/..

11

Pembrolizumab plus enfortumab vedotin in urothelial cancer:

Santoni, Matteo ; Takeshita, Hideki ; Massari, Francesco...
Nature Reviews Urology. , 2024

Link: https://doi.org/10.1038/..

12

TERT promoter mutations and the outcome of patients with ad..:

Mollica, Veronica ; Tassinari, Elisa ; Santoni, Matteo...
Pathology - Research and Practice. 253 (2024) - p. 155008 , 2024

Link: https://doi.org/10.1016/..

13

Chromosome 3p gene alterations as biomarkers for immunocomb..:

Rosellini, Matteo ; Mollica, Veronica ; Marchetti, Andrea...
Pathology - Research and Practice. 254 (2024) - p. 155142 , 2024

Link: https://doi.org/10.1016/..

14

Belzutifan: enhancing the blockade of angiogenesis in renal..:

Mollica, Veronica ; Massari, Francesco
The Lancet Oncology. 24 (2023) 5 - p. 423-425 , 2023

Link: https://doi.org/10.1016/..

15

Bone targeting agents, but not radiation therapy, improves ..:

Santoni, Matteo ; Massari, Francesco ; Takeshita, Hideki...
Clinical and Experimental Medicine. 23 (2023) 8 - p. 5413-5422 , 2023

Link: https://doi.org/10.1007/..